These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11974441)

  • 1. [Ma Huang, from dietary supplement to abuse].
    Arditti J; Bourdon JH; Spadari M; de Haro L; Richard N; Valli M
    Acta Clin Belg; 2002; 57 Suppl 1():34-6. PubMed ID: 11974441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ma Huang, du complement alimentaire a l'abus.
    Arditti J; Bourdon JH; Spadari M; de Haro L; Richard N; Valli M
    Acta Clin Belg; 2002; 57 Suppl 1():34-6. PubMed ID: 24862522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
    Haller CA; Benowitz NL
    N Engl J Med; 2000 Dec; 343(25):1833-8. PubMed ID: 11117974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements.
    Haller CA; Duan M; Benowitz NL; Jacob P
    J Anal Toxicol; 2004 Apr; 28(3):145-51. PubMed ID: 15107143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine.
    Samenuk D; Link MS; Homoud MK; Contreras R; Theoharides TC; Wang PJ; Estes NA
    Mayo Clin Proc; 2002 Jan; 77(1):12-6. PubMed ID: 11795249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ephedra-containing dietary supplements in the US versus ephedra as a Chinese medicine.
    Mehendale SR; Bauer BA; Yuan CS
    Am J Chin Med; 2004; 32(1):1-10. PubMed ID: 15154280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of ephedra alkaloids: a comprehensive review.
    Andraws R; Chawla P; Brown DL
    Prog Cardiovasc Dis; 2005; 47(4):217-25. PubMed ID: 15991150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.
    Boozer CN; Daly PA; Homel P; Solomon JL; Blanchard D; Nasser JA; Strauss R; Meredith T
    Int J Obes Relat Metab Disord; 2002 May; 26(5):593-604. PubMed ID: 12032741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric symptoms associated with ephedra use.
    Maglione M; Miotto K; Iguchi M; Hilton L; Shekelle P
    Expert Opin Drug Saf; 2005 Sep; 4(5):879-84. PubMed ID: 16111450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery aneurysm and thrombosis following chronic ephedra use.
    Flanagan CM; Kaesberg JL; Mitchell ES; Ferguson MA; Haigney MC
    Int J Cardiol; 2010 Feb; 139(1):e11-3. PubMed ID: 18718687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events.
    Maglione M; Miotto K; Iguchi M; Jungvig L; Morton SC; Shekelle PG
    Am J Psychiatry; 2005 Jan; 162(1):189-91. PubMed ID: 15625222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-huang) as determined by high performance liquid chromatography.
    Gurley BJ; Wang P; Gardner SF
    J Pharm Sci; 1998 Dec; 87(12):1547-53. PubMed ID: 10189265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations.
    Haller CA; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2005 Jun; 77(6):560-71. PubMed ID: 15961987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
    Nykamp DL; Fackih MN; Compton AL
    Ann Pharmacother; 2004 May; 38(5):812-6. PubMed ID: 15026566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability of weight-loss supplements: Results of an audit of retail outlets in a southeastern city.
    Sharpe PA; Granner ML; Conway JM; Ainsworth BE; Dobre M
    J Am Diet Assoc; 2006 Dec; 106(12):2045-51. PubMed ID: 17126636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Increase in Dietary Supplement Exposures Reported to US Poison Control Centers.
    Rao N; Spiller HA; Michaels NL; Chounthirath T; Casavant MJ; Kamboj AK; Smith GA
    J Med Toxicol; 2017 Sep; 13(3):227-237. PubMed ID: 28741126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mysterious blood pressure increase in a drilling Naval reservist.
    Wettach GE; Falvey SG
    Mil Med; 2002 Jun; 167(6):521-3. PubMed ID: 12099092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common dietary supplements for weight loss.
    Saper RB; Eisenberg DM; Phillips RS
    Am Fam Physician; 2004 Nov; 70(9):1731-8. PubMed ID: 15554492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ephedra in perspective--a current review.
    Abourashed EA; El-Alfy AT; Khan IA; Walker L
    Phytother Res; 2003 Aug; 17(7):703-12. PubMed ID: 12916063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ephedra banned.
    Cockey CD
    AWHONN Lifelines; 2004; 8(1):19-25. PubMed ID: 15031882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.